Viltolarsen
Generic name: Viltolarsen
Brand names: Viltepso
Dosage form: intravenous solution (50 mg/mL)
Drug class:
Miscellaneous uncategorized agents
Usage of Viltolarsen
Viltolarsen is used to treat Duchenne muscular dystrophy in adults and children who have a certain gene mutation. Your doctor will test you for this gene mutation.
Viltolarsen was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, some people responded to viltolarsen, but further studies are needed.
Viltolarsen may also be used for purposes not listed in this medication guide.
Viltolarsen side effects
Get emergency medical help if you have signs of an allergic reaction: hives, itching, rash, blistering or peeling; fever; difficult breathing; swelling of your face, lips, tongue, or throat.
Viltolarsen may cause serious side effects. Call your doctor at once if you have:
Common side effects of viltolarsen may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Viltolarsen
Tell your doctor if you have ever had kidney problems.
Tell your doctor if you are pregnant or breastfeeding.
Relate drugs
- Absorica
- Absorica LD
- Adakveo
- Aminohippurate sodium
- Ammonul
- Amondys 45
- Amphadase
- Amphadase injection
- Collagenase clostridium histolyticum
- Collagenase clostridium histolyticum-aaes
- Crizanlizumab
- Crizanlizumab-tmca
- Cystagon
- Cysteamine
- Cysteamine (Oral)
- Betibeglogene autotemcel
- Carbaglu
- Carglumic acid
- Casimersen
- Chlorophyllin
- Chymopapain
- Daprodustat
- Delandistrogene moxeparvovec-rokl
- Deoxycholic acid
- Derifil
- Dexrazoxane
- Dextranomer and sodium hyaluronate
- Elevidys
- Elivaldogene autotemcel
- Esbriet
- Eteplirsen
- Etranacogene dezaparvovec-drlb
- Evrysdi
- Exondys 51
- Fecal microbiota, live-jslm
- Golodirsen
- Hemgenix
- Hemin
- Hyaluronidase
- Hyaluronidase injection
- Hydase
- Hylenex
- Hylenex injection
- Jesduvroq
- Kepivance
- Kinevac
- Kybella
- Methacholine
- Nusinersen
- Nusinersen injection
- Omidubicel-onlv
- Omisirge
- Onasemnogene abeparvovec Zolgensma
- Onasemnogene abeparvovec-xioi
- Oxbryta
- Palifermin
- Palovarotene
- Panhematin
- Pirfenidone
- Plasminogen human
- Plasminogen, human-tvmh
- Procysbi
- Protirelin
- Provocholine
- Qwo
- Rebyota
- Risdiplam
- Ryplazim
- Sclerosol Intrapleural
- Sculptra
- Sincalide
- Skysona
- Sodium phenylacetate and benzoate
- Sohonos
- Spinraza
- Steritalc
- Talc
- Thyrel TRH
- Totect
- Viltepso
- Viltolarsen
- Vitrase
- Voxelotor
- Vyondys 53
- Xiaflex
- Zenatane
- Zinecard
- Zolgensma
- Zynteglo
How to use Viltolarsen
Usual Adult Dose for Muscular Dystrophy:
80 mg/kg via IV infusion once a weekComments:-This drug has been approved under an accelerated approval process based on demonstrated increased dystrophin production in skeletal muscle observed in treated patients; continued approval may be contingent upon verification and description of clinical benefit in a confirmatory trial.Use: For the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.
Usual Pediatric Dose for Muscular Dystrophy:
80 mg/kg via IV infusion once a weekComments:-This drug has been approved under an accelerated approval process based on demonstrated increased dystrophin production in skeletal muscle observed in treated patients; continued approval may be contingent upon verification and description of clinical benefit in a confirmatory trial.Use: For the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.
Warnings
Before using viltolarsen tell your doctor about all your medical conditions or allergies, all medicines you use, and if you are pregnant or breastfeeding.
What other drugs will affect Viltolarsen
Other drugs may affect viltolarsen, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions